Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Evaluation of the therapeutic community treatment model in Thailand: policy implications for compulsory and prison-based treatment.

Johnson KW, Young L, Shamblen S, Suresh G, Browne T, Chookhare KW.

Subst Use Misuse. 2012 Jun-Jul;47(8-9):889-909. doi: 10.3109/10826084.2012.663279.

PMID:
22676561
2.

Therapeutic community drug treatment success in Peru: a follow-up outcome study.

Johnson K, Pan Z, Young L, Vanderhoff J, Shamblen S, Browne T, Linfield K, Suresh G.

Subst Abuse Treat Prev Policy. 2008 Dec 3;3:26. doi: 10.1186/1747-597X-3-26.

3.

Not to lose sight of the bigger picture: the case of therapeutic communities (TC) research in closed settings in Thailand.

Vuong T, Ritter A.

Subst Use Misuse. 2013 Jun;48(9):793-4. doi: 10.3109/10826084.2013.791320. No abstract available.

PMID:
23647128
4.

Reply to "Not to lose sight of the bigger picture: the case of therapeutic communities research in closed settings in Thailand".

Johnson KW, Young L, Shamblen S.

Subst Use Misuse. 2013 Dec;48(14):1600-1. doi: 10.3109/10826084.2013.793717. No abstract available.

PMID:
23822736
5.

Modified therapeutic community treatment for offenders with MICA disorders: substance use outcomes.

Sullivan CJ, McKendrick K, Sacks S, Banks S.

Am J Drug Alcohol Abuse. 2007;33(6):823-32.

PMID:
17994478
6.

The success of therapeutic communities for substance abusers in American prisons.

Wexler HK.

J Psychoactive Drugs. 1995 Jan-Mar;27(1):57-66. Review.

PMID:
7602441
7.

Predictors of therapeutic engagement in prison-based drug treatment.

Welsh WN, McGrain PN.

Drug Alcohol Depend. 2008 Aug 1;96(3):271-80. doi: 10.1016/j.drugalcdep.2008.03.019.

PMID:
18486361
8.

Prison-based substance abuse treatment, residential aftercare and recidivism.

Hiller ML, Knight K, Simpson DD.

Addiction. 1999 Jun;94(6):833-42.

PMID:
10665073
9.

[Efficacy of the therapeutic community model in the treatment of drug use-related problems: a systematic review].

Fiestas F, Ponce J.

Rev Peru Med Exp Salud Publica. 2012 Mar;29(1):12-20. Review. Spanish.

10.
11.

Differential effectiveness of residential versus outpatient aftercare for parolees from prison-based therapeutic community treatment programs.

Burdon WM, Dang J, Prendergast ML, Messina NP, Farabee D.

Subst Abuse Treat Prev Policy. 2007 May 15;2:16.

12.

Treatment process in prison therapeutic communities: motivation, participation, and outcome.

Melnick G, De Leon G, Thomas G, Kressel D, Wexler HK.

Am J Drug Alcohol Abuse. 2001 Nov;27(4):633-50.

PMID:
11727881
13.

The results of drug dependence treatment by therapeutic community in Thanyarak Institute on Drug Abuse.

Verachai V, Punjawatnun J, Perfas F.

J Med Assoc Thai. 2003 May;86(5):407-14.

PMID:
12859095
14.

Evaluating component effects of a prison-based treatment continuum.

Butzin CA, Martin SS, Inciardi JA.

J Subst Abuse Treat. 2002 Mar;22(2):63-9.

PMID:
11932131
15.

A day treatment program in a therapeutic community setting: six-month outcomes. The Walden House Day Treatment Program.

Guydish J, Werdegar D, Sorensen JL, Clark W, Acampora A.

J Subst Abuse Treat. 1995 Nov-Dec;12(6):441-7.

PMID:
8749728
16.

Planned duration of residential drug abuse treatment: efficacy versus effectiveness.

McCusker J, Bigelow C, Vickers-Lahti M, Spotts D, Garfield F, Frost R.

Addiction. 1997 Nov;92(11):1467-78.

PMID:
9519490
17.

Reconciling the multiple objectives of prison diversion programs for drug offenders: evidence from Kansas' Senate Bill 123.

Stemen D, Rengifo AF.

Eval Rev. 2011 Dec;35(6):642-72. doi: 10.1177/0193841X12439194.

PMID:
22473494
18.

Therapeutic communities for substance related disorder.

Smith LA, Gates S, Foxcroft D.

Cochrane Database Syst Rev. 2006 Jan 25;(1):CD005338. Review.

PMID:
16437526
19.

One year return to custody rates among co-disordered offenders.

Messina N, Burdon W, Hagopian G, Prendergast M.

Behav Sci Law. 2004;22(4):503-18.

PMID:
15282837
20.

Assessment of a multistage therapeutic community for drug-involved offenders.

Martin SS, Butzin CA, Inciardi JA.

J Psychoactive Drugs. 1995 Jan-Mar;27(1):109-16.

PMID:
7602434

Supplemental Content

Support Center